rs7260613

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003332.4(TYROBP):​c.276+675C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 151,980 control chromosomes in the GnomAD database, including 2,151 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 2151 hom., cov: 31)

Consequence

TYROBP
NM_003332.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.221

Publications

3 publications found
Variant links:
Genes affected
TYROBP (HGNC:12449): (transmembrane immune signaling adaptor TYROBP) This gene encodes a transmembrane signaling polypeptide which contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain. The encoded protein may associate with the killer-cell inhibitory receptor (KIR) family of membrane glycoproteins and may act as an activating signal transduction element. This protein may bind zeta-chain (TCR) associated protein kinase 70kDa (ZAP-70) and spleen tyrosine kinase (SYK) and play a role in signal transduction, bone modeling, brain myelination, and inflammation. Mutations within this gene have been associated with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. Its putative receptor, triggering receptor expressed on myeloid cells 2 (TREM2), also causes PLOSL. Multiple alternative transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Mar 2010]
TYROBP Gene-Disease associations (from GenCC):
  • polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, PanelApp Australia
  • polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.31 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYROBPNM_003332.4 linkc.276+675C>T intron_variant Intron 4 of 4 ENST00000262629.9 NP_003323.1 O43914-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYROBPENST00000262629.9 linkc.276+675C>T intron_variant Intron 4 of 4 1 NM_003332.4 ENSP00000262629.3 O43914-1

Frequencies

GnomAD3 genomes
AF:
0.115
AC:
17427
AN:
151862
Hom.:
2150
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.315
Gnomad AMI
AF:
0.0363
Gnomad AMR
AF:
0.0566
Gnomad ASJ
AF:
0.0527
Gnomad EAS
AF:
0.0399
Gnomad SAS
AF:
0.0553
Gnomad FIN
AF:
0.0435
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0327
Gnomad OTH
AF:
0.0828
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.115
AC:
17439
AN:
151980
Hom.:
2151
Cov.:
31
AF XY:
0.113
AC XY:
8407
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.314
AC:
13012
AN:
41402
American (AMR)
AF:
0.0564
AC:
862
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0527
AC:
183
AN:
3470
East Asian (EAS)
AF:
0.0400
AC:
207
AN:
5174
South Asian (SAS)
AF:
0.0551
AC:
266
AN:
4828
European-Finnish (FIN)
AF:
0.0435
AC:
459
AN:
10560
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0327
AC:
2223
AN:
67968
Other (OTH)
AF:
0.0819
AC:
172
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
640
1281
1921
2562
3202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0626
Hom.:
311
Bravo
AF:
0.125
Asia WGS
AF:
0.0590
AC:
205
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.9
DANN
Benign
0.64
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7260613; hg19: chr19-36397445; API